Phospholemman (PLM) is a 72-residue bitopic cardiac transmembrane protein, which acts as a modulator of the Na ؉ /K ؉ -ATPase and the Na ؉ /Ca 2؉ exchanger and possibly forms taurine channels in nonheart tissue. This work presents a high resolution structural model obtained from a combination of site-specific infrared spectroscopy and experimentally constrained high throughput molecular dynamics (MD) simulations. Altogether, 37 experimental constraints, including nine long range orientational constraints, have been used during MD simulations in an explicit lipid bilayer/water system. The resulting tetrameric ␣-helical bundle has an average helix tilt of 7.3°a nd a crossing angle close to 0°. It does not reveal a hydrophilic pore, but instead strong interactions between various residues occlude any pore. The helix-helix packing is unusual, with Gly
Human phospholemman (PLM)2 is a member of a family of single-span transmembrane proteins characterized by the invariant extracellular motif FXYD (1) and is also known as FXYD1. It is found in liver, skeletal muscle, and most abundantly in the cardiac sarcolemma (2). Over recent years, conclusive experimental evidence has been presented that PLM acts as a tissue-specific modulator of the Na ϩ /K ϩ -ATPase similar to the other members of the FXYD family, each of which is prevalent in a different tissue, summarized in several recent reviews (3, 4). The Na ϩ /K ϩ -ATPase consists of a catalytic ␣-subunit with 10 transmembrane segments and a -subunit involved in membrane insertion and as a modulator of transport properties (5). In particular, cross-linking and modeling studies revealed the direct interaction between the Na ϩ /K ϩ -ATPase ␣-subunit and members of the FXYD family (␥ and CHIF), which involves the binding of a single transmembrane domain into a groove formed by M2, M6, and M9 transmembrane helices of the Na ϩ /K ϩ -ATPase (6, 7). PLM appears to be a major control point in the function of heart cells, although its specific physiological role is unclear, complicated by the possibility that its regulatory effect on the Na ϩ /K ϩ -ATPase may depend on the phosphorylation state of PLM (8) as well as other less well established functional roles (e.g. interaction with the Na/Ca 2ϩ exchanger (9, 10) or independent channel formation). PLM knock-out mice expressed a complex response, including increased cardiac mass, larger cardiomyocytes, and ejection fractions in the absence of hypertension, whereas the overall Na ϩ /K ϩ -ATPase activity was reduced by 50% (11). There is growing evidence that PLM regulates the activity of Na/Ca 2ϩ exchanger 1 (NCX1) from heterologous expression studies of PLM and NCX1 in HEK239 cells (10) and overexpression of PLM in rat cardiomyocytes (12, 13) using different approaches to measure NCX1 activity. It appears that phosphorylation of PLM abolishes its inhibitory effect on the Na ϩ /K ϩ -ATPase (14, 15), whereas the phosphorylated form of PLM inhibits NCX1 (9, 12).Electrical measurements of PLM in artificial lipid bilayers and oocytes sh...